Ann E. Eakin

Affiliations: 
University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Pharmacy, Molecular Biology
Google:
"Ann Eakin"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Basarab GS, Manchester JI, Bist S, et al. (2013) Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents. Journal of Medicinal Chemistry. 56: 8712-35
Mills SD, Eakin AE, Buurman ET, et al. (2011) Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo. Antimicrobial Agents and Chemotherapy. 55: 1088-96
Craig SP, Eakin AE. (2005) Purine salvage enzymes of parasites as targets for structure-based inhibitor design. Parasitology Today (Personal Ed.). 13: 238-41
Wenck MA, Medrano FJ, Eakin AE, et al. (2004) Steady-state kinetics of the hypoxanthine phosphoribosyltransferase from Trypanosoma cruzi. Biochimica Et Biophysica Acta. 1700: 11-8
Butterworth AC, Medrano FJ, Eakin AE, et al. (2004) Saturation mutagenesis, complement selection, and steady-state kinetic studies illuminate the roles of invariant residues in active site loop I of the hypoxanthine phosphoribosyltransferase from Trypanosoma cruzi. Biochimica Et Biophysica Acta. 1699: 87-94
Canyuk B, Medrano FJ, Wenck MA, et al. (2004) Interactions at the dimer interface influence the relative efficiencies for purine nucleotide synthesis and pyrophosphorolysis in a phosphoribosyltransferase. Journal of Molecular Biology. 335: 905-21
Medrano FJ, Wenck MA, Eakin AE, et al. (2003) Functional roles for amino acids in active site loop II of a hypoxanthine phosphoribosyltransferase. Biochimica Et Biophysica Acta. 1650: 105-16
Barnes BJ, Izydore RA, Eakin AE, et al. (2001) Mechanism of action of the antitumor agents 6-benzoyl-3,3-disubstituted-1,5-diazabicyclo[3.1.0]hexane-2,4-diones: potent inhibitors of human type II inosine 5'-monophosphate dehydrogenase. International Journal of Cancer. Journal International Du Cancer. 94: 275-81
Lee CC, Medrano FJ, Craig SP, et al. (2001) Investigation of the functional role of active site loop II in a hypoxanthine phosphoribosyltransferase. Biochimica Et Biophysica Acta. 1537: 63-70
Barnes BJ, Eakin AE, Izydore RA, et al. (2001) Implications of selective type II IMP dehydrogenase (IMPDH) inhibition by the 6-ethoxycarbonyl-3,3-disubstituted-1,5-diazabicyclo[3.1.0]hexane-2,4-diones on tumor cell death. Biochemical Pharmacology. 62: 91-100
See more...